Published December 2006 | Version v1
Journal article

Effects of insulin-like growth factor-I on bone metabolism in patients with liver cirrhosis

  • 1. Putuo District People's Hospital, Shanghai (China). Dept. of Gastroenterology

Description

To study the effects of serum insulin-like growth factor-I (IGF-I) on bone metabolism in liver cirrhosis, 44 patients with hepatic cirrhosis were divided into 3 groups according to disease severity (Child Pugh Score) and 38 healthy subjects served as controls. Serum levels of IGF-I and osteocalcin(BGP) were measured in all patients and controls. Results showed that levels of IGF-I, BGP, and BMD were lower significantly in patients with liver cirrhosis than that in controls. When the condition of cirrhosis more deteriorated, these changes became much lower significantly. Serum levels of BGP and BMD were positively correlated with IGF-I. The decreasing level of IGF-I might be an important factor causing osteoporosis in patients with liver cirrhosis. (authors)

Additional details

Publishing Information

Journal Title
Labeled Immunoassays and Clinical Medicine
Journal Volume
13
Journal Issue
4
Journal Page Range
p. 193-195
ISSN
1006-1703

Optional Information

Notes
2 tabs., 8 refs.